# Intraoperative Tumor Margin Identification With ICG Dye Imaging

> **NCT04752137** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Benign Neoplasm
- Malignant Neoplasm

## Interventions

- **DRUG:** Indocyanine green
- **DEVICE:** SPY-PHI

## Key facts

- **NCT ID:** NCT04752137
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-25
- **Primary completion:** 2028-04-01
- **Final completion:** 2030-04-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04752137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04752137, "Intraoperative Tumor Margin Identification With ICG Dye Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04752137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*